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Background: The loss of cortical neuron environment integrity is the hallmark of
neurodegeneration diseases such as Alzheimer’s disease (AD) and amnestic mild
cognitive impairment (aMCI). To reveal the microenvironment changes in cerebral cortex,
the current study aimed to examine the changes of mean diffusivity (MD) in parcellated
brain among AD, aMCI patients and normal controls (NC).
Methods : Diffusion tensor imaging data with the whole brain coverage were acquired
from 28 AD (aged 69.4 ± 8.2 year old), 41 aMCI patients (aged 68.2 ± 6.4 year old) and
40 NC subjects (aged 65.7± 6.4 year old). Subsequently, theMD values were parcellated
according to the standard automatic anatomic labeling (AAL) template. Only the 90
regions located in the cerebral cortex were used in the final analysis. The mean values of
MD from each brain region were extracted and compared among the participant groups.
The integrity of the white matter tracts and gray matter atrophy was analyzed using the
track-based spatial statistics and voxel-based morphometry approaches, respectively.
Results : Significant differences of MD were noticed both in aMCI and AD patients,
in terms of the affected regions and the amount of increase. The hippocampus,
parahippocampal gyrus and cingulum were the most significantly affected regions in AD
patients. From all the 90 cerebral cortex regions, significant increase of MD in the AD
patients was found in 40 regions, compared to only one (fusiform gyrus on the right) in
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aMCI patients. In the disease affected regions, the MD from aMCI patients is in state
between NC and AD patients.
Conclusions : Increased MD in the specific regions of the brain shows the feasibility of
MD as an indicator of the early stage cortical degeneration in aMCI and AD patients.
Keywords: Alzheimer disease, mild cognitive impairment, cerebral cortex, diffusion MRI, parcellation
INTRODUCTION
Alzheimer’s disease (AD), a progressive neurodegenerative
disease, is the most common form of dementia (Alzheimer’s,
2014). In 2014, nearly 44 million population worldwide were
affected by Alzheimer’s or related dementia and expected to
almost triple in 2050 (Prince et al., 2014). However, only 1-
in-4 people with AD have been correctly diagnosed (Prince
et al., 2014). Neuropathological studies showed that patients with
AD are often accompanied with the deposition of amyloid and
neurofibrillary tangle (NFT), which initiates from the temporal
lobe and subsequently spreads out to the whole brain in the later
stage (Braak and Braak, 1991). The accumulation of amyloid and
NFT leads to neural death and brain shrinkage (Braak and Braak,
1991). Patients with AD suffer from the loss of brain functions,
which typically starts with the impairment of the short-term
memory in the early stage and extends to the long-term memory
loss. The typical survival time from onset of AD to death varies
from 4 to 8 years after the first diagnosis.
Mild cognitive impairment (MCI) refers to a specific
group of patients who show deficits in the neuropsychological
performance but do not satisfy the criteria of dementia (Petersen
et al., 2001). Patients with amnestic type MCI (aMCI) have
early memory complaints either with or without impairment
in additional cognitive domains (Petersen et al., 1999). After a
follow-up of 6 years approximately 80% of aMCI patients are
diagnosed with AD (Petersen et al., 1999). It was noticed that
this specific subgroup of patients will convert to AD at a rate
3∼6 times higher when compared with the healthy subjects
(Thompson et al., 2007). As a result, patients with aMCI are
considered as a high-risk group of precursory AD (Prince et al.,
2014). The understanding of the neuro-structural alterations in
patients with aMCI, as related to the memory impairment, will
potentially lead to a new insight of the underlying pathogenesis
mechanism of AD.
Magnetic resonance imaging (MRI), a noninvasive imaging
tool and free from ionizing radiation, has been used to study the
extent of neuro-structural degeneration in patients with AD (Du
et al., 2001; Thompson et al., 2007; Whitwell et al., 2008; Burton
et al., 2009). The typical volumetric measurement in the brains
of patients with AD reported atrophy in medial temporal lobe
(MTL), hippocampus and the entorhinal cortex (Du et al., 2001;
Burton et al., 2009). Similarly, atrophy in patients with aMCI also
starts from hippocampus and entorhinal cortex (Whitwell et al.,
2008). Post-mortem studies (Braak and Braak, 1991) showed
that AD affected neurodegeneration sequence could initiate from
medial temporal lobe and subsequently involve the whole brain.
This similarity in the brain atrophy pattern further supports the
hypothesis that aMCI could be a transition stage between the
healthy status and AD (Ahmed et al., 2008). However, the brain
atrophy by itself is not specific to the patients with AD. The
morphological changes can only be detected at an advanced stage
when the volume loss is no longer recoverable. Therefore, an
image probe that is capable of detecting the subtle changes in the
brain at an earlier stage of the disease is highly desirable.
Diffusion tensor imaging (DTI) allows for the measurement
of micro-scale displacement of water molecules using MRI in
a non-invasive manner. It could measure the water diffusivity
in the brain in vivo, which is a reflection of the brain tissue
integrity (Basser and Pierpaoli, 1996). Mean diffusivity (MD) is
the average of water diffusivity measured along all directions
(Basser and Pierpaoli, 1996). In a free and isotropic environment,
the measured MD is approximately 3 × 10−3 mm2/s (Helenius
et al., 2002). In the biological environment, water diffusion could
be restricted and hindered. MD is approximately 0.89 × 10−3
mm2/s in the cortical gray matter and 0.70 × 10−3 mm2/s in
white matter (Helenius et al., 2002).
Because the alteration in neuronal function might precede the
structural atrophy, the current study proposed to investigate the
value of changes in MD as an early sign of the neurodegeneration
sequence in the natural course of Alzheimer Disease. Previous
DTI studies on AD and/or aMCI mostly focused on either
the changes in white matter tracts or the hypothesis-driven
regions of interest such as hippocampus, entorhinal cortex and
its neighborhood (Fellgiebel et al., 2004; Mielke et al., 2009). The
most vulnerable white matter tracts involve uncinate fasciculus,
superior longitudinal fasciculus, inferior longitudinal fasciculus
and splenium of the corpus callosum (Liu et al., 2011; Wai et al.,
2014), indicating a global influence of the brain from the aMCI
and AD. Significantly increased MD in pathologically related
structures can be found in hippocampus, cingulum and corpus
callosum (Fellgiebel et al., 2004). However, the white matter
degeneration could be secondary to the gray matter damage
(Zhang et al., 2009). Therefore, the investigation into the general
involvement of MD in the cortex is of great interest.
The MD value is a reflection of the balance between the
different cellular contributions. Because the water diffusivity
from the extracellular space could be larger than the intracellular
component, the increased MD is often related to an increased
extracellular volume (Duong et al., 1998), as a result of the
collapse of neural integrity (Schaefer et al., 2000). The increased
MD has been reported in the patients with neurodegenerative
diseases, for example, Parkinson’s disease, and was attributed to
the microstructural alterations such as neural death (Lu et al.,
2016). Because the neurodegeneration sequence often begin with
the loss of neural integrity and result in the cell death in the end
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(Tripathi, 2012), the MD might showed increased sensitivity to
the early sign of neurodegeneration.
In the present study, the hypothesis is that different extents
of cortical damages between aMCI and AD can be detected by
MD. Therefore, this study aimed to investigate the changes in
MD as measured in cerebral cortex and assessed its potential as
an early marker of neurodegeneration. Mean diffusivity from the
parcellated cortical brain regions were measured. The differences
between aMCI and AD in each region were examined. The
correlation between the MD and cognitive performance was
analyzed.
METHODS
The study was approved by the Institutional Review Board
of Chang Gung Medical Foundation in Linkou, Taiwan, and
complied with the Declaration of Helsinki. All participants gave
written informed consent before participating the study.
Participants
The participants were divided into three age-range matched
groups, which consists of 40 healthy normal controls (NC,
Male/Female = 22/18, aged 65.4 ± 6.2 year old), 41 patients
with aMCI (Male/Female = 20/21, aged 68.3 ± 6.7 year old)
and 28 patients with AD (Male/Female = 11/17, aged 68.5 ±
7.9 year old). All subjects were screened by a medical history
review, physical examination, and neuropsychological testing.
The physical examination, and neuropsychological testing was
performed within 2 weeks of the MR examinations. Four key
cognitive domains were assessed: memory, executive function,
language and visuospatial skills. The neuropsychological
assessments performed in this study including the Mini-
Mental State Examination (MMSE), clinical dementia rating
(CDR); word sequence learning-recall, visual reproduction,
logic memory II in the memory function evaluation; semantic
association of verbal fluency, Wisconsin Card Sorting Test
(WCST) completed categories, Wechsler Adult Intelligence
Scale-III (WAIS-III) digit symbol-scaled, WAIS-III digit span-
scaled in executive function evaluation; 3-D block construction
Models in visuospatial evaluation, and object naming test in the
language function evaluation. Subjects with depressive symptoms
were excluded by using either the Hamilton Depression Rating
Scale (NC) or the Cornell scale for depression in dementia (AD
and aMCI). The general exclusion criteria for MRI examination
also applied. The Apolopoprotein E status were also examined if
available.
The diagnosis of AD was made by using NINCDS-ADRDA
criteria (McKhann et al., 1984). The MCI patients were
determined by the criteria of Petersens et al. (Petersen, 2004).
An aMCI patient was defined as patient with MCI and memory
impairment. The healthy controls were identified as cognitively
normal, judged by clinical assessment and neuropsychological
testing. The demographic data are summarized in Table 1.
Image Acquisition
Images were acquired using a 3T MR scanner (MAGNETOM
Trio a TIM system, Siemens, Erlangen, Germany). T2
TABLE 1 | General characteristics of the study participants and
neuropsychological evaluation scores.
Control (n = 40) aMCI (n = 41) AD (n = 28)
Mean age 65.4 (6.2) 68.3 (6.7) 68.3 (7.7)
Gender (Male/Female) 22/18 20/21 11/17
Education 10.4 (4.3)* 6.8 (5.1) 6.1 (5.2)#
Hypertension (w/o) 8/40 24/41 11/28
APOLIPOPROTEIN E STATUS
ε4 carriers 0 9 4
ε4 noncarriers 22 14 12
Unknown 18 18 12
MEAN GLOBAL SCORE
MMSE (Maximum 30) 28.6 (1.1)* 23.7 (4.9)# 14.6 (6.1)#$
Clinical dementia rating (CDR) 0.0 (0.0)* 0.5 (0.0)# 1.0 (0.6)#$
MEAN MEMORY SCORE
Word sequence learning-recall 3.4 (1.7)* 0.2 (0.4)# 0.0 (0.0)#
Visual reproduction II 12.1 (2.7)* 8.0 (2.9)# 5.3 (1.3)#$
Logic memory II 12.3 (2.8)* 6.7 (3.9)# 2.4 (1.1)#$
MEAN EXECUTIVE FUNCTION SCORE
Semantic association of verbal
fluency
34.8 (7.1)* 28.7 (6.9)# 15.4 (7.4)#$
WCST-S completed categories 5.4 (1.1)* 3.4 (1.9)# 1.7 (2.9)#
WAIS-III digit symbol-scaled 10.7 (2.7)* 8.5 (3.3) 5.0 (2.7)#$
WAIS-III digit span-scaled 11.7 (2.8)* 9.8 (2.8) 7.6 (2.3)#
MEAN VISUOSPATIAL SCORE
3-D block construction models 28.7 (0.6)* 26.9 (3.7) 19.1 (10.1)#$
MEAN LANGUAGE SCORE
Object naming test 16.0 (0.0)* 15.9 (0.5) 13.1 (4.4)#$
Mean (standard deviation); MMSE, Mini–mental state examination; WCST-S, Wisconsin
Card Sorting Test-short form; WAIS-III, Wechsler Adult Intelligence Scale-III; *indicates
significant difference among three groups. # indicates significant difference between
patients and normal controls. $ indicates significant different between aMCI and AD
patients.
fluid-attenuated inversion recovery and T1-weighted
magnetization-prepared rapid acquisition gradient echo (T1-
MPRAGE) images were acquired to rule out the concomitant
neurological disorders. T1-MPRAGE images were subsequently
used in post-processing for data normalization. The following
imaging parameters were used: repetition time (TR)/echo time
(TE) = 2000ms/2.63ms, 160 axial slices of voxel size = 1 × 1
× 1 mm3, inversion time = 900 ms, flip angle = 9 degree. The
single acquisition time was 4min 08 s.
Diffusion weighted images were acquired using spin-echo
echo planar imaging (EPI) sequence with the following
parameters: TR/TE = 7324ms/83ms, 64 axial slices of voxel
size = 2 × 2 × 2mm3, b-value 1000 s/mm2 with the diffusion
weighted gradient applied along 64 non-collinear directions. The
single average acquisition time was 8min 47 s.
Image Processing and Analysis
The Cortical Parcellation
The procedure of image parcellation followed Lu et al.
(2016) by homemade code in MATLAB (MATLAB 2013a.
The MathWorks, Inc., Natick, Massachusetts, United States).
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The calculation and spatial normalization of the diffusion
tensor were performed with Camino toolbox (Cook et al.,
2006) (Microstructure Imaging Group—University College
London) following the recommended procedure and parameters.
The MD values were parcellated according to the standard
automatic anatomic labeling (AAL) template following Ng et al.
(2013). Briefly, non-diffusion weighted image (B0) from each
individual was normalized to the ICBM 152 template from
Montreal Neurological Institute (MNI) space 12-parameter affine
transformation. The parameters used in the transformation
were subsequently applied to MD of the same individual. The
normalized MD was parcellated according to the AAL atlas. The
mean values of MD from the 90 cortical regions were used in the
final analysis.
Track-Based Spatial Statistics
In order to determine the extent of white matter involvement,
track-based spatial statistics (TBSS, part of FMRIB Software
Library Smith et al., 2004) was performed following its
recommended procedure and settings. The difference in
white matter skeleton between groups was calculated using
Randomized permutation program (with 100,000 times
permutations) (Nichols and Holmes, 2002).
Voxel-Based Morphometry
Brain atrophy was assessed by Voxel-Based Morphometry
(VBM) using the analysis toolbox from Statistical Parametric
Mapping 8 (Wellcome Department of Imaging Neuroscience,
London (Friston et al., 1994). The T1-MPRAGE images from
all subjects were normalized to the standard MNI space and
segmented into gray matter, white matter as well as cerebrospinal
fluid within the same generative model. The normalized gray
matter images were smoothed with a Gaussian kernel 8 × 8 ×
8mm FWHM.
Statistical Analyses
All the statistical analyses were performed in PASW Statistics
21 (IBM Corp. Released 2012. IBM SPSS Statistics for
Windows. Armonk, NY: IBM Corp.). The threshold of statistical
significance was considered with Bonferroni post hoc correction.
In the comparison of mean values among subject groups
including the clinical neuropsychological scores and cortical
MD values, one-way Analysis of variance (ANOVA) with post
hoc multiple comparisons (Tukey honestly significant difference
test). The statistical significance level was based on p < 0.05.
Correction for multiple comparison was applied by using
Bonferroni method (p-value < 0.0005, Bonferroni: 0.05/90). The
correlation between cortical MD and the neuropsychological
scores was performed with controlled aging effect after
Bonferroni multiple comparison correction (p-value < 5.6E-5,
Bonferroni: 0.05/900).
In TBSS, family wise error (FWE) correction was performed
to correct for multiple comparison, with a threshold of p <
0.05. The abnormal white matter tracts were identified based on
the atlas prepared at Johns Hopkins University (Wakana et al.,
2004). In VBM, differences in gray matter between groups were
assessed using two-sample t-test with threshold of p < 0.05 at
false discovery rate (FDR).
RESULTS
Clinical Evaluation
Among the groups (NC, aMCI, andAD), no significant difference
was noticed in gender, age and education level (Table 1).
Compared to NC, AD patients had significant declination in
all neuropsychological tests (p < 0.001). Compared to aMCI
patients, AD patients showed reduced cognitive function in all
tasks except for the learning-recall test of memory function,
the completed categories test of executive function and the
object naming test of language function. In addition, patients
with aMCI had disturbed functions in the mean global and
memory functions, semantic association of verbal fluency and
the complete categories of Wisconsin card sorting test. No
Apolipoprotein ε4 (ApoE4) carriers were found in NC. Nine
of 41 aMCI patients and 4 of 28 AD patients were ApoE4
carrier.
Gray Matter Changes in Patients
Compared to NC, aMCI showed increased cortical MD in the
right fusiform. In contrast, wide spread regions (Figure 1A, violet
colored, 39 AAL regions) with significant increase MD can be
found in AD patients, mainly located within the temporal lobe
and cingulate gyrus. When comparing AD patients to aMCI,
significantly increased MD was noticed in 10 cortical regions
(Figure 1B, violet colored), including the bilateral hippocampus,
bilateral posterior cingulum, right anterior cingulum, right
amygdala, right caudate and left cuneus.
Both patients with aMCI and AD performed volumetric
loss in cortical regions. The atrophy regions in aMCI were
found in bilateral hippocampus and right parahippocampal
gyrus, when compared to NC. In contrast, atrophy regions
were found in AD patients mostly in temporal, parietal and
frontal lobes, including the hippocampus, insula, fusiform,
superior temporal gyrus, olfactory, and the inferior frontal
triangularis (Figure 1A, warm colors). In addition, AD patients
showed atrophic regions mainly hippocampus, fusiform gyrus,
insula, olfactory gyrus, middle temporal gyrus and inferior
frontal triangularis when compared to aMCI (Figure 1B, warm
colors).
Increased Cortical MD in AD and aMCI
Patients
The increased MD pattern among patients with aMCI and
AD was showed in Figure 2. Initial MD increase can be
observed in aMCI patients only located in the right fusiform
(green color), when compared to NC. Compared to aMCI
patients, AD patients showed expended regions of increased
MD (yellow color), such as hippocampus, parahippocampus,
amygdala, inferior temporal gyrus, cuneus, precuneus, anterior
cingulum and posterior cingulum. In the later stage, increaedMD
regions can be observed in every lobe of cortical brain in AD
patinets (red color), compared to NC. Significant difference in
the MD values were found in different cortical regions among
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FIGURE 1 | Regions with increased mean diffusivity (MD) and gray
matter loss in Alzheimer’s disease (AD) patients, compared to normal
controls (A) and amenstic mild cognitive impairment (aMCI) patients
(B). The regions with significant increase MD are plotted with violet and the
regions with gary matter atophy are plotted with warm colors, and the brighter
color means the more severe atrophy in gray matter. The major atrophy
regions were labeled with anatomy.
the groups in comparison (Figure 3, stars: between AD and
NC; pounds: aMCI and NC; plus: aMCI and AD). Although
both patient groups have significantly increased MD in cortical
regions, the amount of change and the affected regions from
the aMCI patients is always less than AD. The left hippocampus
was the site with the most significant increase (p < 0.00001,
12.51% increase in AD patients), when compared to NC. In
the affected regions, MD increased by 7.52% in AD patients on
average.
White Matter Changes in Patients
To identify the difference in the involvement of white matter,
the difference of TBSS in between aMCI and NC was shown
in Figure 4. Significant changes can be noticed in right
superior longitudinal fasciculus (SLF), internal and external
FIGURE 2 | Increased mean diffusivity (MD) pattern among patint with
amenstic mild cognitive impairment (aMCI) and Alzheimer’s disease
(AD). Initial MD increase can be observed in aMCI patients only located in the
right fusiform (violet color), when compared to normal controls (NC). Compared
to aMCI patients, AD patients showed expended regions of increased MD
(yellow color). In the later stage, increaed MD regions can be observed in every
lobe of cortical brain in AD patinets (red color), compared to NC. This spatial
distribution pattern of regions with increased MD is similar to the post-mortem
pathology of amyloid deposition in AD patients (Braak and Braak, 1991).
capsule (Figure 4A). A general increase of MD was noticed
throughout the whole brain (Figure 4B). However, no significant
difference in white matter was found between the aMCI and AD
patients.
Correlation Analysis in aMCI and AD
Patients
Table 2 summarizes the cortical regions with significant
correlation between MD and neuropsychological scores.
Hippocampus and its neighborhood in the temporal lobe,
such as fusiform gyrus and inferior temporal gyrus, are the
main regions with significant correlation the functions of
interest.
MD in the olfactory cortex and amygdala were significantly
correlated with scores of Mini–Mental State Examination
(MMSE) and Clinical Dementia Rating (CDR). The learning
recall score of memory function was significantly correlated in
regions located in the inferior frontal gyrus pars triangularis. The
regions with correlation to semantic verbal fluency appeared to
be scattered in the whole brain. The Wechsler Adult Intelligence
Scale (WAIS-III) digit symbol-scaled score were significantly
correlated with regions located in calcarine and lingual gyrus.
In the visuospatial test, the 3-D block construction score
significantly correlated with the cingulum, middle occipital,
cuneus, lingual and angular gyrus. In the language function test,
the object naming score was correlated with inferior parietal
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FIGURE 3 | Mean diffusivity (MD) in parcellated cortical regions. The mean diffusivity in parcellated cortical regions with significant difference between Alzhimer’s
disease (AD) patients and normal controls (NC). Cortical MD of AD patients (solid), amnestic mild cognitive impairment (aMCI) (gray) patietents and NC (blank) are
plotted. Stars indicate the significant difference between aMCI patients and NC (p < 0.0005). Pounds indicate the significant differences between aMCI and NC
(p < 0.0005). Plus indicate the significant differences between aMCI and AD patients (p < 0.0005). The AAL cortical regions are arranged into temporal (A), frontal (B),
occipital (C), parietal (D), and the deep nuclear (E). The regions are numbered according to the anatomical automatic labeling template. Mean diffusivity is given in
units of *10−3 mm2/s.
and angular gyrus. No significant correlation was found between
education level and MD.
DISCUSSION
Major Findings
The current study reported an increased number of affected
cortical regions and with growing difference, as the disease
progressed from aMCI to AD. We measured the cortical mean
diffusivity from two patient groups in comparison to the NC.
Significant differences between AD and aMCI groups can be
noticed in two aspects: the spatial pattern of the affected
regions and the magnitude of increase. Although the atrophic
pattern in AD suggested the whole brain involvement, the
current study provided image based in vivo evidence that
the microstructural damage might begin at an earlier stage.
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FIGURE 4 | The tract-based spatial statistics results of aMCI patients (A) and AD patients (B), when compared to normal controls. The white matter tract
skelotons are plotted in green lines and the pixels with significant MD increase are marked with red on tracts. The major regions with increased MD were labeled with
anatomy.
The spatial distribution suggested the involved regions might
extend beyond the temporal lobe. The increase in mean
diffusivity, a reflection of the severity in damage, indicated
a widespread cortical impairment from MCI to AD. This
spatial distribution pattern of regions with increased MD is
similar to the post mortem pathology of amyloid deposition
in AD patients (Braak and Braak, 1991). Furthermore, the
affected region is consistent with that from the volumetric
atrophy. Because the increase of MD is often attributed to
an increase from the extracellular volume (Syková, 2004),
as a result of the potential cell death, our observation
might suggest a microstructural damage due to cellular
degeneration or neural demyelination (Basser and Pierpaoli,
1996). Besides, significant correlations between the MD from
the affected regions and the neuropsychological scores were
observed.
Increased MD in aMCI Patients
In the aMCI patients, the current study observed significant
atrophy located in the bilateral hippocampus, with increased
MD in the peripheral region, noticeably fusiform gyrus. Only
the right fusiform showed significant increase in MD (p =
0.0005, percentage increase of 4.35%). Similar increase of MD
was noticed in bilateral hippocampi (Left side: p= 0.001, increase
= 4.98%; Right side: p = 0.03, increase = 3.37%). Although the
difference did not reach statistical significance, the percentage
increase from left hippocampus is even higher than that in the
right fusiform.
The white matter damage indicated that a more distant
region could be affected such as SLF (Figure 4A). Post-mortem
study showed that the brain degeneration in aMCI (Braak and
Braak, 1991) started from the hippocampus and spread into
the surrounding area in the later stages. The increased cortical
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TABLE 2 | Regions with significant correlation between MD and neuropsychological scores.
Neuropsychological scores Cortical region (correlation coefficient, p-value)
MMSE Olfa. R. (−0.41, 1.21E-5) Cing. Ant. R. (-0.41, 9.62E-6)
Cing. Post. L. (−0.46, 8.67E-7) Cing. Post. R. (-0.45, 1.22E-6)
Hipp. L. (−0.53, 6.90E-9) Hipp. R. (−0.50, 4.83E-8)
ParaHipp. L. (−0.54, 1.23E-9) ParaHipp. R. (−0.44, 3.77E-6)
Calc. L. (−0.43, 2.79E-6) Calc. R. (−0.38, 4.79E-5)
Ling L. (−0.43, 4.07E-6) Occi. Mid. L. (−0.39, 4.13E-5)
Fusi. L. (−0.58, 5.51E-11) Fusi. R. (−0.53, 5.26E-9)
Caud. R. (−0.42, 9.08E-6) Thal. L. (−0.38, 5.09E-5)
Temp. Inf. L. (−0.45, 1.51E-6)
CDR Olfa. R. (0.42, 1.03E-5) Hipp. L. (0.44, 2.00E-6)
Hipp.R. (0.54, 3.02E-9) ParaHipp. L. (0.44, 2.25E-6)
ParaHipp. R. (0.47, 6.07E-7) Amyg. L. (0.41, 2.72E-5)
Amyg. R. (0.49, 1.21E-7) Fusi. L. (0.44, 1.54E-6)
Fusi. R. (0.51, 3.59E-8) Caud. L. (0.42, 7.39E-6)
Caud. R. (0.43, 3.76E-6) Temp. Inf. L. (0.40, 1.98E-5)
MEMORY FUNCTION
Learning recall Front. Inf. Oper. R. (−0.40, 4.06E-5) Hipp. L. (−0.48, 5.82E-7)
Fusi. R. (−0.40, 3.64E-5)
Visual reprodiction Hipp. L. (−0.46, 1.54E-6) Hipp. R. (−0.41, 1.65E-5)
ParaHipp. L. (−0.53, 1.00E-8) ParaHipp. R. (−0.50, 7.91E-8)
Amyg. L. (−0.40, 5.14E-5) Fusi. L. (−0.52, 2.31E-8)
Fusi. R. (−0.50, 9.87E-8) Temp. Inf. L. (−0.40, 3.12E-5)
Logic memory Hipp. L. (−0.56, 7.80E-10) Hipp. R. (−0.48, 3.64E-7)
ParaHipp. L. (−0.52, 1.49E-8) ParaHipp. R. (−0.53, 1.11E-8)
Amyg. L. (−0.54, 3.38E-6) Calc. L. (−0.44, 2.91E-5)
Fusi. L. (−0.50, 6.71E-8) Fusi. R. (−0.50, 1.45E-7)
Temp. Inf. L. (−0.45, 1.87E-6)
EXECUTIVE FUNCTION
Semantic association of verbal fluency Front. Sup. Orb. L. (−0.43, 5.25E-6) Front. Mid. L. (−0.40, 3.00E-5)
Front. Mid. R. (−0.45, 1.63E-5) Front. Mid. Orb. L. (−0.43, 6.80E-6)
Front. Inf. Oper. R. (−0.41, 2.05E-5) Front. Inf. Tri. L. (−0.41, 1.64E-5)
Olfa. L. (−0.51, 4.25E-8) Olfa. R. (−0.45, 2.71E-6)
Cing. Ant. L. (−0.48, 2.93E-7) Cing. Post L. (−0.47, 5.75E-7)
Cing. Ant. R. (−0.45, 1.92E-6) Hipp. L. (−0.50, 9.70E-8)
Cing. Post R. (−0.43, 5.21E-6) ParaHipp. L. (−0.49, 1.67E-7)
Hipp. R. (−0.51, 3.21E-8) Amyg. R. (−0.41, 2.53E-5)
ParaHipp. R. (−0.59, 8.46E-11) Calc. R. (−0.46, 9.59E-7)
Calc. L. (−0.44, 3.83E-6) Ling. L. (−0.48, 3.16E-7)
Cuneus L. (−0.41, 1.61E-5) Fusi. R. (−0.54, 7.71E-9)
Fusi. L. (−0.62, 2.77E-12) Caud. L. (−0.45, 1.97E-6)
Precuneus L. (−0.44, 3.33E-6) Temp. Sup. L. (−0.43, 6.01E-6)
Caud. R. (−0.45, 1.80E-6) Temp. Mid. L. (−0.57, 3.56E-10)
Temp. Sup. R. (−0.41, 1.73E-5) Temp. Pole Mid. L. (−0.42, 1.21E-5)
Temp. Mid. R. (−0.47, 5.53E-7) Temp. Inf. L. (−0.60, 2.42E-11)
Temp. Pole Mid. R. (−0.41, 1.79E-5) Temp. Inf. R. (−0.46, 1.16E-6)
WCST-S completed categories ParaHipp. R. (−0.43, 1.11E-5)
WAIS-III digit symbol-scaled Hipp. L. (−0.45, 7.81E-6) Hipp. R. (−0.44, 1.49E-5)
(Continued)
Frontiers in Aging Neuroscience | www.frontiersin.org 8 January 2017 | Volume 8 | Article 325
Lin et al. Increased Cortical MD in aMCI and AD
TABLE 2 | Continued
Neuropsychological scores Cortical region (correlation coefficient, p-value)
ParaHipp. R. (−0.43, 2.64E-5) Calc. L. (−0.42, 2.84E-5)
Ling. L. (−0.41, 4.11E-5) Fusi. L. (−0.49, 7.46E-7)
Fusi. R. (−0.50, 6.06E-7)
VISUALSPATIAL FUNCTION
3-D block construction Models Cing. Ant. R. (−0.39, 4.16E-5) Cing. Mid. R. (−0.40, 3.05E-5)
Cing. Post L. (−0.41, 1.61E-5) Cing. Post R. (−0.45, 2.02E-6)
Hipp. L. (−0.42, 1.25E-5) Calc. L. (−0.47, 6.86E-7)
Cuneus L. (−0.49, 1.39E-7) Ling. L. (−0.41, 2.00E-5)
Occi. Mid. L. (−0.55, 2.56E-9) Occi. Inf. L. (−0.41, 1.94E-5)
Fusi. L. (−0.54, 4.05E-9) Fusi. R. (−0.48, 3.79E-7)
Angular L. (−0.39, 5.07E-5) Angular R. (−0.43, 5.53E-6)
Precuneus L. (−0.43, 6.85E-6) Temp. Mid. L. (−0.41, 1.71E-5)
Temp. Inf. L. (−0.41, 1.66E-5) Temp. Inf. R. (−0.41, 1.56E-5)
LANGUAGE FUNCTION
Object naming test Hipp. L. (−0.46, 9.50E-7) Hipp. R. (−0.40, 2.91E-5)
ParaHipp. L. (−0.51, 2.39E-8) Amyg. L. (−0.41, 3.19E-5)
Amyg. R. (−0.44, 4.28E-6) Occi. Mid. L. (−0.49, 1.13E-7)
Fusi. L. (−0.59, 5.47E-11) Fusi. R. (−0.54, 6.17E-9)
Parietal Sup. L. (−0.39, 3.46E-5) Parietal Sup. R. (−0.39, 3.41E-5)
Parietal Inf. L. (−0.47, 5.88E-7) Angular L. (−0.41, 1.51E-5)
Temp. Sup. L. (−0.39, 3.19E-5) Temp. Pole Sup. L. (−0.47, 4.77E-7)
Temp. Mid. L. (−0.60, 1.68E-11) Temp. Mid. R. (−0.43, 5.46E-6)
Temp. Pole Mid. R. (−0.46, 6.21E-7) Temp. Inf. L. (−0.66, 2.74E-14)
Regions with significant correlation between to MD and neurophyscological scores. R., right side; L., Left side; Front. Sup. Orb., superior frontal gyrus; Front. Mid., Middle frontal gyrus;
Front. Inf. Oper, opercular part of inferior frontal gyrus; Front. Inf. Tri., triangular part of inferior frontal gyrus; Olfa., olfactory gyrus; Cing. Ant., anterior cingulum; Cing. Mid., middle part
of cingulum; Cing. Post, posterior cingulum; Hipp., hippocampus; ParaHipp., parahippocampal gyrus; Amyg., amygdala; Calc., calcarine gyrus; Cuneus, cuneus gyrus; Ling., lingual
gyrus; Occi. Mid., middle occipital gyrus; Occi. Inf., inferior occipital gyrus; Fusi., fusiform gyrus; Parietal Sup., Superior parietal gyrus; Parietal Inf., inferior parietal gyrus; Angular, angular
gyrus; Caud., caudate nucleus; Thal., thalamus; Temp. Sup., superior temporal gyrus; Temp. Pole Sup., temporal pole of superior temporal gyrus; Temp. Mid., middle temporal gyrus;
Temp. Pole Mid., temporal pole of middle temporal gyrus; Temp. Inf., inferior temporal gyrus.
MD in right fusiform might be related to the functions of word
recognition and within-category identification (McCarthy et al.,
1997). The finding is consistent with the reduced performance
in verbal fluency and completed categories tasks in this specific
group of patients. The gray matter atrophy pattern in the
hippocampus might be related to the potential damage in
memory formation and storage (Burgess et al., 2002), as observed
in the impaired memory functions.
Increased MD of the right SLF might suggest declination
in the microstructural integrity within this region. The SLF
structurally connects with the temporal, occipital and frontal
lobes, which is functionally associated with the memory
formation and higher cognitive functions such as verbal fluency
(Kamali et al., 2014). In addition, the loss of integrity of white
matter tracts which connected to gray matter with memory
function has been associated to AD-risk (Gold et al., 2012).
Increased MD in SLF could be potentially more sensitive to
neurodegeneration than the volumetric atrophy.
Affected Neural Network in AD Patients
Increased MD was observed in widespread cortical regions
of the AD patients. The spatial distribution of the involved
regions was similar to that in beta-amyloid deposition and
neurofibrillary tangle (Braak and Braak, 1991). This similarity
might suggest possible association between changes in MD and
the disruption within the neuronal environment. This spatial
pattern of increased MD is also consistent with gray matter
atrophy, similar to the previous report (Burton et al., 2009). The
region with the most significant increase of MD and the most
severe volumetric atrophy are both located in the hippocampus.
Because hippocampus and the entorhinal cortex are involved in
consolidating information from short-term memory into long-
term memory (Schwindt and Black, 2009), the dysfunction in
these regions are the hallmark of the AD pathology (Braak and
Braak, 1991; Du et al., 2001). The increase ofMD in hippocampus
might attribute to the memory loss in our study (Table 1).
The affected white matter tracts in AD mainly located in
bilateral uncinate fasciculus, SLF, and cingulum (Figure 4B).
These affected tracts involves in the connection between the
frontal, temporal and occipital lobes in neocortex (Friederici,
2011). It can be noticed that the cortical MD in the
surrounding area was significantly increased. This observation
might suggest that a more extensive neural network might
be involved, as reflected in the increase of MD. In addition,
the degeneration of the cingulum involved the development of
cognitive impairment in AD (Bozzali et al., 2012), which might
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refer to the significant cognitive dysfunction in our AD patient
group.
Enhanced Cortical Involvement from aMCI
to AD
Compared with aMCI, more extensive cortical regions were
involved in AD patients (one cortical region in aMCI patient and
40 in AD patients). Both the increase of MD and the involved
regions suggest that the aMCI patients in the current study are in
a transition state between the NC and AD patients. More severe
brain degeneration in the more severe brain degeneration can
be observed in AD patients when compared to aMCI. However,
in term of white matter involvement, no significant difference
between AD patients and aMCI can be found. This observation
might support the fact that white matter changes could be
secondary to the neurodegeneration in AD type dementia.
The current study noticed an overlap between the regions of
graymatter atrophy and themore extensive and widespread areas
of increased MD (Figure 1). The neurodegeneration process
(Tripathi, 2012) begins with the loss of neural integrity, which
subsequently evolve into massive cell death and shrinkage,
and thus ultimately resulted in volumetric reduction and brain
atrophy. The increase of MD is often attributed to the underlying
microstructural damage. Because the spatial distribution pattern
of the involved regions, as indicated by the increase of mean
diffusivity, is similar to the post-mortem pathology of amyloid
deposition in AD (Braak and Braak, 1991) and is more extensive
than the atrophy map. It might suggest an increased sensitivity
in the changes of MD than tissue atrophy. This observation
certainly warrants new interest in further investigation in the
future.
Correlation between MD and
Neuropsychological Performance
Hippocampus, fusiform and inferior temporal gyrus were
mainly negative correlated with the cognitive evaluation scores.
The previous studies reported that the hippocampus atrophy
associated with not only loss of memory formation but
also executive dysfunction such as non-memory cognitive
impairment in early AD and aMCI patients (Burgess et al.,
2002; Nagata et al., 2011). The current finding suggested that
the degeneration of hippocampus and its surroundings were
not only the landmark of aMCI and AD, but also involved
the reduction of clinical cognitive performance in every aspect
of evaluation including memory executive, visuospatial and
language functions.
In addition to the hippocampus, different regions of cortical
MDwith significant correlation were noticed in different tasks for
cognitive performance scores. Specifically, the memory function
(the learning recall task) test showed negative correlation to MD
in inferior frontal gyrus pars triangularis on left side, which
has been known as a critical role in memory retrieval (Badre
and Wagner, 2007). A scattered spatial pattern of cortical MD
was also correlated with the semantic verbal fluency task of the
executive function tests. The damage in cortical regions might
interrupt the network of executive function including the ability
of attention, planning and execution (Zhang et al., 2009; Nagata
et al., 2011).
Deficits in visuospatial function in patients with aMCI andAD
may suggest the loss of integrity of visual processing network.
The middle occipital, cuneus and angular gyrus were noticed
with significant correlation to the 3D block construction of the
visuospatial test, which are critical roles involved the visuospatial
information process (Bone, 2001). Interestingly, the regions with
significant correlation between visuospatial function and cortical
MD were mainly found on the left side. Although a lateralized
brain network in visuospatial function were reported (Thiebaut
de Schotten et al., 2011), the association between laterality of
visuospatial function and cortical brain degeneration might need
for further investigation.
Effect of Apolipoprotein E ε4 Allele
Apolipoprotein ε4 (ApoE4) carriers could be found in patients
with MCI and AD. The ApoE4 is the most widely known
genetic risk factor for sporadic AD in different ethnic groups
(Sadigh-Eteghad et al., 2012). However, Wai et al have reported
a mild impact of the ApoE4 status on the extent of white matter
disruption in the aMCI patients (Wai et al., 2014). The present
study did not found significant trend between of the ApoE4
carrier and aMCI/AD. Number of ApoE4 carriers in aMCI/AD
patient groups were smaller than non-carriers. Interestingly, the
previous study has showed that the ApoE4 is less common
in Chinese people than Caucasians or Japanese (Wong et al.,
2005), which could explain the observation of leak of association
between ApoE4 and AD/aMCI.
Limitations
The major limitation in the current study is a compromised
spatial resolution in a template-based parcellation approach, each
of which consisted of multiple voxels. This might lead to the
potential statistical type I error. In a template-based parcellation
approach, the MD value is an average from all voxels within
the region of interest. If the observed effect within the region
is heterogeneous, the statistical significance might be affected.
Furthermore, the inhomogeneous nature and limited number of
aMCI participants might reduce the sensitivity of detection. To
establish a relationship between MD and the amyloid deposition
is an interesting and important issue, which will have to be
investigated in the animal study in the future because biopsy
is impossible in human neurodegeneration study. Secondly, the
diagnosis remains clinical, based on psychometric evaluation
(Petersen, 2004). In the study design, only age and gender in
the participants were matched. This data inhomogeneity, as
shown in MMSE, is one major limitation in the current study,
which to an extent reflected the difficulty in the diagnosis of
the neurodegenerative disease, specifically Alzheimer Disease.
Objective evidences such as neuroimaging-based and genome-
based might improve the accuracy of clinical judgment. Finally,
because the APOE status remained uncertain for a significant
amount of the participants because they did not provide the
blood sample for examination, this might lead to concerns
in the reliability of the result for the effects of APOE in
neuroimaging.
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CONCLUSIONS
The current study identified a specific spatial pattern in the cortex
of increased MD from patients with aMCI or AD. A correlation
between MD and neuropsychological evaluations were reported
between the functionally related cortical regions. The findings
demonstrated the possibility of MD as an indicator at the early
stage of cortical degeneration.
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